Oncology Nursing News®

Oncology Nursing Articles

Expert Discusses Violence Against Nurses

Expert Discusses Violence Against Nurses

BY BRIELLE BENYON

Addressing Racial Disparities in Mesothelioma Treatment in Real-Time

Addressing Racial Disparities in Mesothelioma Treatment in Real-Time

BY CONOR KILLMURRAY

Partial-Breast Radiation Promising for Some Breast Cancer Survivors

Partial-Breast Radiation Promising for Some Breast Cancer Survivors

BY BRIELLE BENYON

The HER2-Positive Metastatic Breast Cancer Landscape Could Gain a New Combination Treatment

The HER2-Positive Metastatic Breast Cancer Landscape Could Gain a New Combination Treatment

BY JASON M. BRODERICK

MET Inhibitor Tepotinib is Granted a Breakthrough Designation by the FDA

MET Inhibitor Tepotinib is Granted a Breakthrough Designation by the FDA

BY GINA COLUMBUS

New Targeted Therapies for EGFR-mutated and HER2-positive NSCLC Have Emerged

New Targeted Therapies for EGFR-mutated and HER2-positive NSCLC Have Emerged

BY CONOR KILLMURRAY

For Patients with KRAS G12C-mutated NSCLC a New Inhibitor Was Granted a Fast Track Designation

For Patients with KRAS G12C-mutated NSCLC a New Inhibitor Was Granted a Fast Track Designation

BY LISA ASTOR

Keeping Track of the Most Recent Treatment Updates

Keeping Track of the Most Recent Treatment Updates

BY LAURA S. WOOD, RN, MSN, OCN

Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles

Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles

BY CONOR KILLMURRAY

A New First-Line Treatment for Patients with METex14-Mutated NSCLC is Granted a Breakthrough Designation by the FDA

A New First-Line Treatment for Patients with METex14-Mutated NSCLC is Granted a Breakthrough Designation by the FDA

BY GINA COLUMBUS

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.